ADvance II, Mild Alzheimers Study

The ADvance II Study is evaluating the Vercise™ Deep Brain Stimulation System,
an FDA-designated "Breakthrough Device".

Email Address

Company:

Mailing Address

Cell

Landline

By clicking Yes, I consent to receive text messages regarding this study. I understand that my consent is not a condition of participation.
Yes, I accept
No, I do not wish to receive text messages

Click here to acknowledge that you accept our Online Privacy Notice, available at the foot of this website.
Yes, I accept the Online Privacy Notice

Modal1 Modal2

Modal Header

This website uses cookies

Marketing: Facebook

Statistics : Vimeo

Statistics : Google analytics

Details & Consent

...

Consent label

GDPR

...

...